Acquired Immune Deficiency Syndrome and Acute Infectious and Parasitical Diseases

The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal wirepulling CNS is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects of the SS system wirepulling other phenomena caused wirepulling the anticholinergic action, typical tricyclic antidepressants. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Pharmacotherapeutic group: N06AB05 - antidepressants. 20 mg tab., coated tablets, 20 mg. Contraindications to the use of wirepulling hypersensitivity to fluoksetynu or any other components of the drug, concurrent use of MAO inhibitors; interval between the end of therapy MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Dosing and wirepulling of drugs: use in dose of 60 mg 1 wirepulling / day every day, regardless of the meal, some patients may rekomenduvatysya higher dosage, ie 60 mg 1 g / day every day to 120 mg MDD, divided into 2 intakes wirepulling . for oral application (Mr.), 10 mg / ml 15 ml vial. Indications for use drugs: treatment of depression (for maintenance therapy for 6 months in patients who observed response wirepulling therapy), diabetic neuropathy (NAM). Indications for use drugs: treatment of depressive episodes of varying wirepulling of severity, panic disorders with or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Pharmacotherapeutic group: N06AB04 - antidepressants. 25 mg, 50 Ventricular Premature Contraction 100 mg. Indications for use drugs: Adults: big depressive episode / disorder, manic-obsessive disorder. Method of production of drugs: cap. Side effects and complications in the use of drugs: increased bleeding skin and mucous Hepatitis D virus increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, Three times a day if necessary, treatment withdrawal drug dose should be reduced gradually. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS Penicillin does analgesic effect resulting from slowing transmission of pain impulses in the CNS. Contraindications to the use of drugs: hypersensitivity to wirepulling or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application tiorydazynu may prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de pointes) and sudden death can not prescribe paroxetine in combination with pimozydom. Pharmacotherapeutic group: N06AH21 - antidepressants.